TRAF7 and neoplasm: KLF4K409Q/TRAF7 tumours exhibited reduced activity score for several signalling pathways (Supplementary Fig. S3), while NF2−/− tumours showed increase activity in pathways like Sirtuin signalling and Protein kinase A, albeit with generally lower protein level modulation (Supplementary Fig. S4).